Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-025369

Chief Financial Officer sold 1,000 shares at $233.47 ($233,470)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-08 Sale : show line 1 in the form 10b5-1 −1,000 $233.47 $233,470 95,812 D
Open-market sales · 1,000 sh · avg $233.47 · $233,470
Loading xslF345X05/form4.xml…